Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
106.49B
Market cap106.49B
Price-Earnings ratio
31.45
Price-Earnings ratio31.45
Dividend yield
Dividend yield
Average volume
17.06M
Average volume17.06M
High today
$66.88
High today$66.88
Low today
$64.81
Low today$64.81
Open price
$65.57
Open price$65.57
Volume
23.75M
Volume23.75M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$59.39
52 Week low$59.39

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $65.74. The company's market cap stands at 106.49B, with a P/E ratio of 31.45.

During the trading session on 2026-04-23, Boston Scientific(BSX) shares reached a daily high of $66.88 and a low of $64.81. At a current price of $65.74, the stock is +1.4% higher than the low and still -1.7% under the high.

Trading activity shows a volume of 23.75M, compared to an average daily volume of 17.06M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $59.39.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $59.39.

BSX News

TipRanks 7h
Boston Scientific price target lowered to $100 from $105 at RBC Capital

RBC Capital lowered the firm’s price target on Boston Scientific (BSX) to $100 from $105 and keeps an Outperform rating on the shares. The stock rose after the...

Benzinga 7h
Boston Scientific Analysts Slash Their Forecasts After Q1 Earnings

Boston Scientific Corporation (NYSE:BSX) reported upbeat earnings for the first quarter on Wednesday. The company posted first-quarter 2026 revenues of $5.20 b...

Boston Scientific Analysts Slash Their Forecasts After Q1 Earnings
Nasdaq 9h
Company News for Apr 23, 2026

AST SpaceMobile, Inc. ( ASTS ) shares rose 5.8% after securing Federal Communications Commission approval for its satellite-based cellular broadband plan. ASTS...

Company News for Apr 23, 2026

Analyst ratings

97%

of 37 ratings
Buy
97.3%
Hold
2.7%
Sell
0%

More BSX News

TipRanks 19h
Boston Scientific Balances Strong Q1 With Softer Outlook

Boston Scientific ((BSX)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 30% Off TipRanks Unlock hedge fund-level data and po...

Simply Wall St 19h
Boston Scientific Trial Wins And Approvals Contrast With Recent Share Weakness

Q1 2026, Boston Scientific (NYSE:BSX) reported positive clinical trial results for the WATCHMAN FLX Left Atrial Appendage Closure Device and the EKOS Endovascul...

Boston Scientific Trial Wins And Approvals Contrast With Recent Share Weakness
Nasdaq 22h
Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations

Boston Scientific (NYSE:BSX), a medical device developer, closed Wednesday at $64.87, up 8.99%. The stock is jumping after a Q1 earnings beat paired with lowere...

Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations
TipRanks 23h
Boston Scientific: Sustained Outperformance and Solid Growth Support Buy Rating Despite Trimmed Target

Michael Matson, an analyst from Needham, maintained the Buy rating on Boston Scientific. The associated price target was lowered to $77.00. Unlock hedge fund-l...

TipRanks 1d
Boston Scientific: Proactive Guidance Reset and Resilient Growth Support Buy Rating Despite Lowered Target

Analyst Josh Jennings of TD Cowen maintained a Buy rating on Boston Scientific, reducing the price target to $80.00. Claim 30% Off TipRanks Unlock hedge fund-le...

Benzinga 1d
Why Is Boston Scientific Stock Soaring Wednesday?

Sales increased 11.6% on a reported basis, within the company’s guidance range of 10.5%-12%, and 9.4% on an operational and organic basis, within the company’s...

Why Is Boston Scientific Stock Soaring Wednesday?
TipRanks 1d
Here’s Why Boston Scientific Stock Is Up 10% Today

The stock of Boston Scientific (BSX) is up 10% on April 22 after the medical device maker issued financial results that topped Wall Street’s forecasts. Claim 30...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.